加载中...
广告
发布时间 | 所属地区 | 所属机构 | 语言 |
---|---|---|---|
2024年05月14日 | -- | -- | 英语 (English) 中文 |
Published date: 10 May 2024 Open opportunity - This means that the contract is currently active, and the buying department is looking for potential suppliers to fulfil the contract.
Closing: 14 June 2024, 4pm
Contract summaryIndustryResearch laboratory services - 73111000 Location of contractSP4 0JQ Value of contract£720,000 Procurement referencetender_435903/1352313 Published date10 May 2024 Closing date14 June 2024 Closing time4pm Contract start date1 July 2024 Contract end date31 March 2030 Contract typeSupply contract Procedure typeOpen procedure (above threshold) Any interested supplier may submit a tender in response to an opportunity notice. This procedure can be used for procurements above the relevant contract value threshold. Contract is suitable for SMEs?Yes Contract is suitable for VCSEs?No DescriptionThe Authority requires the production of batches of purified monoclonal antibody (mAb) derived from hybridoma cell lines. The Authority will supply the contractor with cell lines as Government Furnished Assets (GFA) with the requirement that they are cultured and monoclonal antibodies purified from growth media. Requests will be for approximately 20 batches per year of 20 mg and approximately 10 batches of 100 mg of purified IgG over a 6 year period. How to applyFollow the instructions given in the description or the more information section.
|
上一篇:
8-Pan Gas High Efficiency L- Shape Frying Range下一篇:
Re-Roofing Works at Ravenscliffe High School猜你喜欢
加载中...
广告